HCPCS Codes Similar to J1299

HCPCS Codes Similar to “J1299” Code.
Injection, eculizumab, 2 mg

Q5151 Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg Code added date: 20250401 Code effective date: 20250401 TXT \| PDF \| XML \| JSON	Q5152 Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg Code added date: 20250401 Code effective date: 20250701 TXT \| PDF \| XML \| JSON
J1300 Injection, eculizumab, 10 mg Code added date: 20080101 Code effective date: 20250401 TXT \| PDF \| XML \| JSON	Q5139 Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg Code added date: 20250101 Code effective date: 20250401 TXT \| PDF \| XML \| JSON
C9024 Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine Code added date: 20180101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON	C9066 Injection, sacituzumab govitecan-hziy, 2.5 mg Code added date: 20201001 Code effective date: 20210101 TXT \| PDF \| XML \| JSON
C9070 Injection, tafasitamab-cxix, 2 mg Code added date: 20210101 Code effective date: 20210401 TXT \| PDF \| XML \| JSON	C9164 Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg) Code added date: 20240101 Code effective date: 20240401 TXT \| PDF \| XML \| JSON
C9291 Injection, aflibercept, 2 mg vial Code added date: 20120401 Code effective date: 20120701 TXT \| PDF \| XML \| JSON	C9302 Injection, zanidatamab-hrii, 2 mg Code added date: 20250401 Code effective date: 20250701 TXT \| PDF \| XML \| JSON
G0532 Take-home supply of nasal nalmefene hydrochloride; one carton of two, 2.7 mg per 0.1 ml nasal sprays (provision of the services by a medicare-enrolled opioid treatment program);( list separately in addition to each primary code) Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	G2082 Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of up to 56 mg of esketamine nasal self-administration, includes 2 hours post-administration observation Code added date: 20200101 Code effective date: 20200101 TXT \| PDF \| XML \| JSON
G2083 Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation Code added date: 20200101 Code effective date: 20200101 TXT \| PDF \| XML \| JSON	G9676 Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period Code added date: 20160101 Code effective date: 20160101 TXT \| PDF \| XML \| JSON